Technavio has been monitoring the intravenous immunoglobulins market and it is poised to grow by USD 6.79 billion during 2020-2024, progressing at a CAGR of about 10% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201105005385/en/
Technavio has announced its latest market research report titled Global Intravenous Immunoglobulins Market 2020-2024 (Graphic: Business Wire)
Technavio’s in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. Download Latest Free Sample Report on COVID-19 Analysis
The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. ADMA Biologics Inc., Baxter International Inc., Bio Products Laboratory Ltd., Biotest AG, CSL Ltd., Grifols SA, Kedrion Spa, LFB SA, Octapharma AG, and Takeda Pharmaceutical Co.